Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

A non-viral plasmid DNA delivery system consisting on a lysine-derived cationic lipid mixed with a fusogenic lipid

dc.contributor.authorMartínez Negro, María
dc.contributor.authorSánchez Arribas, Natalia
dc.contributor.authorGuerrero Martínez, Andrés
dc.contributor.authorMoya, Mª Luisa
dc.contributor.authorTros de Ilarduya, Conchita
dc.contributor.authorMendicuti, Francisco
dc.contributor.authorAicart Sospedra, Emilio
dc.contributor.authorJunquera González, María Elena
dc.date.accessioned2024-10-16T07:34:48Z
dc.date.available2024-10-16T07:34:48Z
dc.date.issued2019
dc.descriptionPORTADA DE REVISTA
dc.description.abstractThe insertion of biocompatible amino acid moieties in non-viral gene nanocarriers is an attractive approach that has been recently gaining interest. In this work, a cationic lipid, consisting of a lysine-derived moiety linked to a C12 chain (LYCl) was combined with a common fusogenic helper lipid (DOPE) and evaluated as a potential vehicle to transfect two plasmid DNAs (encoding green fluorescent protein GFP and luciferase) into COS-7 cells. A multidisciplinary approach has been followed: (i) biophysical characterization based on zeta potential, gel electrophoresis, small-angle X-ray scattering (SAXS), and cryo-transmission electronic microscopy (cryo-TEM); (ii) biological studies by fluorescence assisted cell sorting (FACS), luminometry, and cytotoxicity experiments; and (iii) a computational study of the formation of lipid bilayers and their subsequent stabilization with DNA. The results indicate that LYCl/DOPE nanocarriers are capable of compacting the pDNAs and protecting them efficiently against DNase I degradation, by forming Lalfa lyotropic liquid crystal phases, with an average size of ~200 nm and low polydispersity that facilitate the cellular uptake process. The computational results confirmed that the LYCl/DOPE lipid bilayers are stable and also capable of stabilizing DNA fragments via lipoplex formation, with dimensions consistent with experimental values. The optimum formulations (found at 20% of LYCl content) were able to complete the transfection process efficiently and with high cell viabilities, even improving the outcomes of the positive control Lipo2000*.
dc.description.departmentDepto. de Química Física
dc.description.facultyFac. de Ciencias Químicas
dc.description.fundingtypeDescuento UCM
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades
dc.description.sponsorshipUniversidad Complutense de Madrid
dc.description.sponsorshipUniversidad de Alcalá
dc.description.statuspub
dc.identifier.citationMartínez-Negro M, Sánchez-Arribas N, Guerrero-Martínez A, Moyá ML, Tros De Ilarduya C, Mendicuti F, et al. A Non-Viral Plasmid DNA Delivery System Consisting on a Lysine-Derived Cationic Lipid Mixed with a Fusogenic Lipid. Pharmaceutics 2019;11:632. https://doi.org/10.3390/pharmaceutics11120632
dc.identifier.doi10.3390/pharmaceutics11120632
dc.identifier.issn1999-4923
dc.identifier.officialurlhttps://doi:10.3390/pharmaceutics11120632
dc.identifier.relatedurlwww.mdpi.com/journal/pharmaceutics
dc.identifier.urihttps://hdl.handle.net/20.500.14352/108996
dc.journal.titlePharmaceutics
dc.language.isoeng
dc.page.initial632
dc.relation.projectIDinfo:eu-repo/grantAgreement/MEC//CTQ2015-65972-R
dc.relation.projectIDinfo:eu-repo/grantAgreement/MEC//CTQ2015-64425-C2-1-R
dc.relation.projectIDinfo:eu-repo/grantAgreement/MEC//CTQ2015-64425-C2-2-R
dc.relation.projectIDinfo:eu-repo/grantAgreement/MEC//CTQ2016-80600-P
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN//RTI2018-095844-B-I00
dc.relation.projectIDinfo:eu-repo/grantAgreement/MEC//UCMA05-33-010
dc.relation.projectIDinfo:eu-repo/grantAgreement/MEC//CCGP2017-EXP/027
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.cdu544
dc.subject.keywordLysine-derived cationic lipid
dc.subject.keywordPlasmid DNA
dc.subject.keywordLipoplexes
dc.subject.keywordTransfection
dc.subject.keywordProtection
dc.subject.keywordCompaction
dc.subject.keywordGene delivery
dc.subject.keywordMultilamellar aggregates
dc.subject.keywordMolecular dynamics
dc.subject.ucmQuímica física (Química)
dc.subject.unesco2307 Química Física
dc.titleA non-viral plasmid DNA delivery system consisting on a lysine-derived cationic lipid mixed with a fusogenic lipid
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication
relation.isAuthorOfPublicationb21e6658-9ad1-4fed-bbf1-e41299c40c84
relation.isAuthorOfPublicationd590ed92-7a5f-481b-abb0-42ad5d4dbd42
relation.isAuthorOfPublication22761001-a3ad-4b9e-b47f-bfd3ba5f8a57
relation.isAuthorOfPublication56e24a94-c784-43f3-8f0b-19917deee155
relation.isAuthorOfPublication3d4e45e9-f8ae-4547-8194-1b781fcec865
relation.isAuthorOfPublication.latestForDiscoveryb21e6658-9ad1-4fed-bbf1-e41299c40c84

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pharmaceutics_LYCL_DOPE_pDNA_2019.pdf
Size:
1.65 MB
Format:
Adobe Portable Document Format

Collections